METTL1 over expression, on the other hand, promotes oncogenic cell transformation and cancer.51 We discovered that METTL1 was substantially expressed in tumor tissues and NACR resistance groups in our investigation by screening differential genes in patients with variable responses to NACR, and IHC results in the HPA database validated this conclusion. The gene discussed is METTL1; the disease is neoplasm.